Nab-Pacshil 100 mg Injection 1's Substitute
Hilfen Pharmaceuticals Pvt Ltd
₹5019
(₹5019.0 per unit)
Admac Lifesciences(Oncology)
₹6159
(₹6159.0 per unit)
Lucien Life Sciences
₹6750
(₹6750.0 per unit)
Taxane Healthcare Pvt Ltd
₹7200
(₹7200.0 per unit)
Sayre Therapeutics Pvt Ltd
₹7500
(₹7500.0 per unit)
Biomak Laboratories Pvt Ltd
₹8906
(₹8906.0 per unit)
Wembrace Biopharma Pvt Ltd
₹9365.5
(₹9365.5 per unit)
Eris Life Sciences Ltd
₹9800
(₹9800.0 per unit)
PERIN HEALTHCARE
₹9843.5
(₹9843.5 per unit)
BDR Pharmaceuticals Internationals Pvt Ltd
₹10192.5
(₹10192.5 per unit)
Delarc Pharmaceuticals Pvt Ltd
₹11433.5
(₹11433.5 per unit)
Therdose Pharma Pvt Ltd
₹11669
(₹11669.0 per unit)
Redvaxin (I) Pvt Ltd
₹11970
(₹11970.0 per unit)
Halsted Pharma Pvt Ltd
₹12000
(₹12000.0 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Nab-Pacshil 100 mg Injection 1's to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - HUMAN ALBUMIN-900MG+PACLITAXEL-100MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Nab-Pacshil 100 mg Injection 1's is used in the treatment of cancer, including breast cancer, pancreatic cancer, and non-small cell lung cancer. The detailed uses of Nab-Pacshil 100 mg Injection 1's are as follows:
Nab-Pacshil 100 mg Injection 1's provides several medicinal benefits when used together. Paclitaxel exhibits anti-cancer properties, inhibiting cell division, stabilizing microtubules, and inducing apoptosis in cancer cells. Human albumin enhances paclitaxel's delivery to cancer cells, improving its solubility and bioavailability. Additionally, human albumin acts as a plasma volume expander and binding agent, transporting essential substances. Together, they enhance cancer treatment efficacy, improve outcomes, reduce side effects, and increase patient survival rates.
RX